All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

  1. Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

    KCE Reports 243 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-diagnosis-and-follow-up-in-birt-hogg-dub%C3%A9-syndrome-familial-atypical-multiple

  2. Oncogenetic testing for persons with hereditary endocrine cancer syndromes

    KCE Reports 242 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-for-persons-with-hereditary-endocrine-cancer-syndromes

  3. Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

    KCE Reports 236 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-and-follow-up-for-women-with-familial-breastovarian-cancer-li-fraumeni-syndrome

  4. Oncogenetic testing for Lynch syndrome and familial adenomatous polyposis

    KCE Reports 220 (2014)

    https://kce.fgov.be/en/oncogenetic-testing-for-lynch-syndrome-and-familial-adenomatous-polyposis

  5. Laboratory tests in general practice

    KCE Reports 59 (2007)

    https://kce.fgov.be/en/laboratory-tests-in-general-practice

  6. [Preoperative risk assessment]

    KCE Reports 5 (2004) The routine peri-operative use of beta-blockers is no longer recommended In the KCE guidelines on pre-surgical examinations (KCE Reports 5-2004), the peri-operative use of beta-blockers (see page 10) was elaborately discussed. These recommendations were largely based on primary studies  To this date (February 2014), it appears that most of these studies are fraudulent. KCE therefore questions the peri-operative  administration of these agents. For more information: http://www.escardio.org/about/press/press-releases/pr-13/Pages/joint-

    https://kce.fgov.be/en/preoperative-risk-assessment